Sompraz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

## Sompraz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp ### Overview Sompraz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp is a brand name for pantoprazole, a proton pump inhibitor (PPI). It reduces gastric acid secretion. ### Primary Indications * Gastroesophageal reflux disease (GERD) * Erosive esophagitis healing * Reduction of risk of NSAID-associated gastric ulcers ### Adult Dosing * **GERD:** 20 mg to 40 mg once daily for up to 4 weeks. * **Erosive Esophagitis:** 40 mg once daily for 4 to 8 weeks. Maintenance therapy: 20 mg once daily. * **NSAID Ulcer Prophylaxis:** 20 mg once daily. Maximum dose: 40 mg daily for most indications, though higher doses may be used under specialist guidance for refractory GERD. ### Pediatric Dosing * **GERD (12 years and older):** 20 mg to 40 mg once daily. * **Erosive Esophagitis (5 years and older):** 20 mg to 40 mg once daily. Dosing in younger children or for specific indications may vary and requires careful consideration. ### Dose Adjustments * **Hepatic Impairment:** Maximum daily dose of 20 mg. * **Renal Impairment:** No dose adjustment typically required. ### Contraindications * Known hypersensitivity to pantoprazole or other PPIs. ### Adverse Effects Common: Diarrhea, headache, nausea, abdominal pain, dizziness. Long-term use associated with: Increased risk of C. difficile infection, bone fractures (hip, wrist, spine), vitamin B12 deficiency, hypomagnesemia, and potentially kidney disease. ### Key Drug Interactions * **Clopidogrel:** Pantoprazole may reduce the efficacy of clopidogrel. Consider alternative PPIs or avoid concomitant use if possible. * **Methotrexate:** PPIs may increase methotrexate levels. * **Drugs dependent on gastric pH for absorption:** (e.g., ketoconazole, itraconazole, iron salts, digoxin) - PPIs can decrease absorption. ### Monitoring * Monitor for signs and symptoms of C. difficile infection. * Consider periodic monitoring of magnesium levels, especially in patients on long-term therapy or concomitant diuretic use. * Assess for bone fracture risk in patients with risk factors. ### Clinical Pearls * Administer 30 minutes to 1 hour before a meal. * For delayed-release formulations, do not crush or chew; swallow whole. * Long-term use should be periodically re-evaluated for necessity. *** *Disclaimer: This information is intended for clinical use and does not replace professional medical advice. Always consult the most current prescribing information and your institution's protocols for definitive guidance.*